Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin‐converting enzyme 2

• Autores principales: Kyungmin Lee (Autor), Yujeong Na (Autor), Minjin Kim (Autor), Dongjin Lee (Autor), Jongseo Choi (Autor), Gwanyoung Kim (Autor), Min‐Soo Kim (Autor)
• Formato: Libro
• Publicado: Wiley, 2024-04-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract The SARS‐CoV‐2 caused COVID‐19 pandemic has posed a global health hazard. While some vaccines have been developed, protection against viral infection is not perfect because of the urgent approval process and the emergence of mutant SARS‐CoV‐2 variants. Here, we employed UDCA as an FXR antag...